ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

331
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
05 Jul 2016 09:24

What the IPOs Completed in Korea Stock Exchange in 1H 2016 Reveal....

If you want to outperform the market, perhaps you should take a look at the IPO market in Korea. In the midst of difficult global IPO markets, the...

Logo
297 Views
Share
16 Feb 2016 00:59

2016 Major IPOs Pipeline in Korea - Part II

In our previous report - 2016 Major IPOs Pipeline in Korea, we identified 19 companies that are seeking to complete IPOs in Korea in 2016. In this...

Logo
237 Views
Share
12 Feb 2016 23:11

2016 Major IPOs Pipeline in Korea

This year appears to be an exciting year for IPOs in Korea, barring a dramatic downturn in global equities markets like the one we experienced in...

Logo
292 Views
Share
x